MBOT Microbot Medical Inc
Price (delayed)
$1.7
Market cap
$28.78M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.8
Enterprise value
$28.35M
Microbot Medical Inc. is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot's current proprietary
Highlights
Microbot Medical's debt has plunged by 62% YoY and by 36% from the previous quarter
Microbot Medical's EPS has increased by 33% YoY
The equity has decreased by 48% YoY and by 37% QoQ
MBOT's quick ratio is down by 42% YoY and by 34% from the previous quarter
Key stats
What are the main financial stats of MBOT
Market
Valuations
Earnings
Shares outstanding
16.93M
Market cap
$28.78M
Enterprise value
$28.35M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.37
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$10.27M
Net income
-$11.21M
EBIT
-$11.21M
EBITDA
-$11.11M
Free cash flow
-$8.97M
Per share
Balance sheet
Liquidity
EPS
-$0.8
EPS diluted
-$0.8
Free cash flow per share
-$0.54
Book value per share
$0.23
Revenue per share
$0
TBVPS
$0.32
Total assets
$5.21M
Total liabilities
$1.4M
Debt
$94,000
Equity
$3.81M
Working capital
$3.62M
Debt to equity
0.02
Current ratio
3.64
Quick ratio
3.2
Net debt/EBITDA
0.04
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-158.2%
Return on equity
-218.3%
Return on invested capital
-307.6%
Return on capital employed
-292%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
MBOT stock price
How has the Microbot Medical stock price performed over time
Intraday
2.41%
1 week
10.39%
1 month
6.92%
1 year
47.83%
YTD
51.79%
QTD
51.79%
Financial performance
How have Microbot Medical's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$10.27M
Net income
-$11.21M
Gross margin
N/A
Net margin
N/A
MBOT's operating income is down by 8% since the previous quarter but it is up by 5% year-on-year
MBOT's net income is down by 7% since the previous quarter and by 6% year-on-year
Growth
What is Microbot Medical's growth rate over time
Valuation
What is Microbot Medical stock price valuation
P/E
N/A
P/B
7.37
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Microbot Medical's EPS has increased by 33% YoY
The stock's price to book (P/B) is 146% more than its 5-year quarterly average of 3.0 and 117% more than its last 4 quarters average of 3.4
The equity has decreased by 48% YoY and by 37% QoQ
Efficiency
How efficient is Microbot Medical business performance
The ROE has contracted by 49% YoY and by 26% from the previous quarter
The company's return on invested capital fell by 38% YoY and by 28% QoQ
MBOT's return on assets is down by 33% year-on-year and by 21% since the previous quarter
Dividends
What is MBOT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for MBOT.
Financial health
How did Microbot Medical financials performed over time
MBOT's quick ratio is down by 42% YoY and by 34% from the previous quarter
The total assets fell by 41% YoY and by 30% QoQ
Microbot Medical's debt is 98% less than its equity
Microbot Medical's debt has plunged by 62% YoY and by 36% from the previous quarter
The equity has decreased by 48% YoY and by 37% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.